Matthew Sexter
Family Medicine · Pasadena, CANPI 1003134560
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,506 of the $16,756 with a category attached, or 68.7%. 26 manufacturers reported payments, led by Braeburn Inc. at 41.2% of the total. 2025 is the largest year on record at $9,774, 3.3 times the $2,951 reported in 2019. Among family medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 246 payments — averaging $68.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Braeburn Inc.$7K
- Gilead$3K
- Johnson & Johnson$2K
- Viiv Healthcare Company$1K
- AbbVie$535
- Alkermes, Inc.$420
- plus $3K from 20 others
What the payments were for
- Speaking & faculty fees$3,99324%
- Travel & lodging$1,2497%
- Food & beverage$11,50669%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Braeburn Inc. | 20 | $6,897 |
| Gilead | 67 | $2,771 |
| Johnson & Johnson(2 entities) | 30 | $1,655 |
| Viiv Healthcare Company | 43 | $1,394 |
| AbbVie | 11 | $535 |
| Alkermes, Inc. | 6 | $420 |
| EMD Serono, Inc. | 11 | $342 |
| Merck | 14 | $323 |
| Neurocrine Biosciences, Inc. | 3 | $306 |
| Incyte Corporation | 2 | $266 |
| Indivior Inc. | 7 | $255 |
| AstraZeneca | 2 | $247 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $243 |
| Napo Pharmaceuticals Inc | 10 | $148 |
| Madrigal Pharmaceuticals | 1 | $135 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Lundbeck LLC | 1 | $121 |
| Shionogi Inc | 1 | $120 |
| Alnylam Pharmaceuticals Inc. | 1 | $99 |
| Lilly USA, LLC | 4 | $72 |
| Theratechnologies Inc. | 3 | $63 |
| Janssen Scientific Affairs, LLC | 2 | $43 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Celltrion, Inc. | 1 | $15 |
| Dynavax Technologies Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BRIXADI$6,656
- INVEGA SUSTENNA$1,139
- ARISTADA$505
- LYBALVI$454
- INVEGA TRINZA$428
- DOVATO$383
- INGREZZA$288
- MONJUVI$266
- Yeztugo$243
- CAPLYTA$243
- Mavyret$240
- Biktarvy$143
- REZDIFFRA$135
- CABENUVA$127
- ARISTADA INITIO$126
- VOQUEZNA$125
- Austedo XR$125
- SUBLOCADE$125
- DATROWAY$123
- Veklury$122
How this compares
$16,756 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.
Other family medicine in Pasadena
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
- Amira AyadBakersfield$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.